Ceftobiprole
In Stock•Starting at $92 for 5 mg•Purity ≥ 96%
| CAS No. | 209467-52-7 |
|---|---|
| MDL No. | N/A |
| MF | C20H22N8O6S2 |
| MW | 534.60 |
| InChI Key | VOAZJEPQLGBXGO-SDAWRPRTSA-N |
| CAS No. | 209467-52-7 |
|---|---|
| MDL No. | N/A |
| MF | C20H22N8O6S2 |
| MW | 534.60 |
| InChI Key | VOAZJEPQLGBXGO-SDAWRPRTSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 96+% | $92 | In Stock | |
| 10 mg | 96+% | $157 | In Stock | |
| 25 mg | 96+% | $319 | In Stock | |
| 50 mg | 96+% | $572 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Ceftobiprole is a fifth-generation cephalosporin antibiotic with (E)-[(3'R)-2-oxo[1,3'-bipyrrolidin]-3-ylidene]methyl at position 3 and [(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino at position 7. It is used for treating hospital-acquired pneumonia (HAP, excluding VAP) and community-acquired pneumonia (CAP). It functions as an antimicrobial agent and is a member of thiadiazoles.
| CAS No. | 209467-52-7 |
|---|---|
| Product Name | Ceftobiprole |